市場調查報告書
商品編碼
815485

脊髓小腦失調的預測:主要14個市場

Epiomic Epidemiology Series: Spinocerebellar Ataxia Forecast in 14 Major Markets 2018-2028

出版日期: | 出版商: Black Swan Analysis | 英文 68 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供主要14個市場 (美國、法國、德國、義大利、西班牙、英國、日本、荷蘭、挪威、中國、韓國、印度、澳洲、葡萄牙) 的脊髓小腦失調的目前患者數 (性別,各年齡世代) 調查分析,目前盛行率,加上疾病概要,危險因素,疾病診斷與預後,主要的症狀和併發症等系統性資訊。

脊髓小腦失調主要的類型與症狀

  • 類型1
  • 類型2
  • 類型3
  • 類型6
  • 類型7
  • 依賴輪椅
  • 眼肌麻痺
  • 錐體路徵候
目錄
Product Code: SCA0010219

image1

Spinocerebellar ataxia (SCA) is an autosomal dominant disease characterised by a slowly progressive lack of coordination, and usually associated with poor gait, hand, speech and eye movements. There are many subtypes of SCA based on which gene is affected, each have their own general age of onset, duration, and typical symptoms. The most well-known subtypes are SCA1, SCA2, SCA3 (Machado-Joseph disease), SCA 6 and SCA7.

This report provides the current prevalent population for Spinocerebellar Ataxia across 14 Major Markets (USA, France, Germany, Italy, Spain, UK, Japan, Netherlands, Norway, China, South Korea, India, Australia, Portugal) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, Spinocerebellar Ataxia patients grouped by type, mobility status and symptoms have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main types and symptoms of Spinocerebellar Ataxia include:

  • Type 1
  • Type 2
  • Type 3
  • Type 6
  • Type 7
  • Wheelchair-dependant
  • Ophthalmoplegia
  • Pyramidal signs

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world-class sources that deliver the most up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Ability to quantify patient populations in global Spinocerebellar Ataxia market to target the development of future products, pricing strategies and launch plans.
  • Further insight into the prevalence of the subdivided types of Spinocerebellar Ataxia and identification of patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Identification of Spinocerebellar Ataxia patient sub-populations that require treatment.
  • Better understanding of the specific markets that have the largest number of Spinocerebellar Ataxia patients.

Country Coverage

image2